Xadcera is an innovative biotechnology company based in China with a global perspective, which focuses on the development of innovative dual anti-ADC drugs with proprietary intellectual property rights.

Xaicure is an innovative biopharmaceutical company focused on the preclinical and clinical development of small molecule targeted drugs, with a research emphasis on cancer treatment.